A carregar...
Strategic Trastuzumab Mediated Crosslinking Driving Concomitant HER2 and HER3 Endocytosis and Degradation in Breast Cancer
Efficacious anticancer therapies for targeting plasma membrane receptors with antibody based therapeutics are often contingent on sufficient endocytic delivery of receptor and conjugate to lysosomes. This results in downregulation of receptor activity and, in the case of antibody-drug conjugates (AD...
Na minha lista:
| Publicado no: | J Cancer |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ivyspring International Publisher
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7097966/ https://ncbi.nlm.nih.gov/pubmed/32231734 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.32470 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|